Use of Cox’s Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete Response
Table 1
Experimental details used for immunohistochemistry.
Antigen
Period used for
Clone
Type
Antigen retrieval
Source
ER
Until Oct 2002
ID5
Mouse monoclonal
A/C citrate buffer
Dako
From Nov 2002 to Feb 2005
ER88
Mouse monoclonal
As above
Bio Genex
From Mar 2005
ID5
Mouse monoclonal
As above
Dako
PgR
Until Oct 2002
IA6
Mouse monoclonal
As above
Novocastra
From Nov 2002 to Feb 2005
PR88
Mouse monoclonal
As above
Bio Genex
From Mar 2005
PgR636
Mouse monoclonal
As above
Dako
HER2
Until Oct 2002
c-erbB-2
Rabbit polyclonal
As above
Dako
From Nov 2002 to Feb 2005
CB11
Mouse monoclonal
As above
Bio Genex
From Mar 2005
c-erbB-2
Rabbit polyclonal
As above
Dako
A/C: autoclave for 10 min at 121°C; ER: estrogen receptor; HER2: human epidermal receptor 2; PgR: progesterone receptor; citrate buffer: 10 mM citrate buffer, pH 6.0.